GlassScriptPhysician profile
Joseph K Choo
NPI 1760468797
$223,559.10
in general payments reported to CMS, 2019-2025
35 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $36K · 2021: $33K · 2022: $30K · 2023: $1,484 · 2024: $19K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Food and Beverage: $10K · Travel and Lodging: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,625.00 |
| Food and Beverage | $10,422.29 |
| Travel and Lodging | $10,339.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $101,358.72 | 2019-2025 | Mitraclip, Triclip, Absolute Pro |
| Janssen Pharmaceuticals, INC | $72,380.60 | 2019-2022 | |
| Edwards Lifesciences Corporation | $13,519.15 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $13,143.40 | 2020-2021 | |
| Boston Scientific Corporation | $11,007.03 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $3,297.15 | 2021-2025 | Corevalve Evolut R, Apollotm, Onyx Frontier |
| Esperion Therapeutics, INC. | $1,980.00 | 2021 | |
| Ancora Heart, INC. | $1,940.23 | 2024-2025 | Accucinch |
| Medtronic Vascular, INC. | $1,380.08 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $463.03 | 2024-2025 | Lifevest |
| Shockwave Medical, INC | $413.54 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Recor Medical INC | $388.30 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Endotronix, INC. | $298.52 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| United Therapeutics Corporation | $250.00 | 2024 | |
| W. L. Gore & Associates, INC. | $208.16 | 2021-2023 | Gore Cardioform Septal Occluder |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $195.14 | 2022-2023 | Pk Papyrus, Orsiro Mission, Recross |
| Teleflex LLC | $185.56 | 2024 | Manta |
| Heartflow, INC. | $150.63 | 2024-2025 | |
| Asahi Intecc USA, INC. | $145.00 | 2025 | Asahi Peripheral Vascular Wires |
| Cvrx, INC. | $128.64 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $125.00 | 2025 | Attruby |
| Philips North America LLC | $91.48 | 2025 | Igt Devices Undivided, Ineb Devices |
| Penumbra, INC. | $91.06 | 2025 | Penumbra System |
| Biosense Webster, INC. | $89.90 | 2024 | Nuvision Ice Catheter |
| Regeneron Healthcare Solutions, INC. | $64.88 | 2019-2021 | |
| Reflow Medical INC | $64.57 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $50.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.15 | 2019-2025 | |
| Chiesi USA, INC. | $25.94 | 2019-2021 | |
| Genentech USA, INC. | $19.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.67 | 2019 | |
| Angiodynamics, INC. | $13.95 | 2025 | Alphavac |
| Pfizer INC. | $12.35 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.18 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Choo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.